Результати пошуку - Shunqing Wang

  • Показ 1 - 17 результатів із 17
Уточнити результати
  1. 1
    miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia

    miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia за авторством Wei Zhou, Shunqing Wang, Ying Yi, Ruiqing Zhou, Ping Mao

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Knowledge, Attitudes, and Practices on Malaria Prevention Among Chinese International Travelers

    Knowledge, Attitudes, and Practices on Malaria Prevention Among Chinese International Travelers за авторством Min Zhang, Zhiyong Liu, Hongtao He, Lan Luo, Shunqing Wang, Honglei Bu, Xian Zhou

    Опубліковано 2011
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis

    Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis за авторством Jianzhong Liu, Shunqing Wang, Ping Zhang, Nasser Said‐Al‐Naief, Suzanne M. Michalek, Xu Feng

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Expression patterns of immune checkpoints in acute myeloid leukemia

    Expression patterns of immune checkpoints in acute myeloid leukemia за авторством Cunte Chen, Chaofeng Liang, Shunqing Wang, Chi Leong Chio, Yuping Zhang, Chengwu Zeng, Shaohua Chen, Caixia Wang, Yangqiu Li

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Carta
    Додати у Вибране
    Збережено в:
  5. 5
    Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia

    Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia за авторством Zhengli Xu, Ming Zhou, Jinsong Jia, Wenjian Mo, Xiaohui Zhang, Yuping Zhang, Yu Wang, Yumiao Li, Xiao‐Jun Huang, Shunqing Wang, Lan‐Ping Xu

    Опубліковано 2019
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

    Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant за авторством Lan‐Ping Xu, Song Jin, Shunqing Wang, Linghui Xia, Hai Bai, Sujun Gao, Qifa Liu, Jianmin Wang, Xin Wang, Ming Jiang, Xi Zhang, Depei Wu, Xiao‐Jun Huang

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Long-term follow-up of haploidentical transplantation in relapsed/refractory severe aplastic anemia: a multicenter prospective study

    Long-term follow-up of haploidentical transplantation in relapsed/refractory severe aplastic anemia: a multicenter prospective study за авторством Lan‐Ping Xu, Zheng‐Li Xu, Shunqing Wang, Depei Wu, Sujun Gao, Jianmin Yang, Linghui Xia, Qifa Liu, Ming Jiang, Hai Bai, Xi Zhang, Xin Wang, Xiao‐Jun Huang

    Опубліковано 2022
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study

    Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study за авторством Zhengli Xu, Lan‐Ping Xu, Depei Wu, Shunqing Wang, Xi Zhang, Rui Xi, Sujun Gao, Linghui Xia, Jianmin Yang, Ming Jiang, Xin Wang, Qifa Liu, Jia Chen, Ming Zhou, Xiao‐Jun Huang

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation

    Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation за авторством Xianping Shi, Xin Chen, Xiaofen Li, Xiaoying Lan, Chong Zhao, Shouting Liu, Hongbiao Huang, Ningning Liu, Siyan Liao, Wenbin Song, Ping Zhou, Shunqing Wang, Li Xu, Xuejun Wang, Q. Ping Dou, Jinbao Liu

    Опубліковано 2013
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China

    A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China за авторством Ying Wang, Depei Wu, Xiang Zhang, Yuhua Li, Yanjie He, Qifa Liu, Xuan Li, Zhenyu Li, Kunming Qi, Yu‐Qian Sun, Shunqing Wang, Wenjian Mo, Lei Gao, Hua Ye, Yu Wang, Ying Zhang

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data

    Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospec... за авторством Sijian Yu, Fen Huang, Zhiping Fan, Li Xuan, Danian Nie, Yajing Xu, Ting Yang, Shunqing Wang, Zujun Jiang, Na Xu, Ren Lin, Jieyu Ye, Dongjun Lin, Jing Sun, Xiao‐Jun Huang, Yu Wang, Qifa Liu

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases

    A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases за авторством Ningning Liu, Chunjiao Liu, Xiaofen Li, Siyan Liao, Wenbin Song, Changshan Yang, Chong Zhao, Hongbiao Huang, Lixia Guan, Peiquan Zhang, Shouting Liu, Xianliang Hua, Xin Chen, Ping Zhou, Xiaoying Lan, Songgang Yi, Shunqing Wang, Xuejun Wang, Q. Ping Dou, Jinbao Liu

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  13. 13
    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label... за авторством Ke Zhao, Ren Lin, Zhiping Fan, Xiaoyong Chen, Yu Wang, Fen Huang, Na Xu, Xi Zhang, Xin Zhang, Li Xuan, Shunqing Wang, Dongjun Lin, Lan Deng, Danian Nie, Jianyu Weng, Yonghua Li, Xiaohui Zhang, Yuhua Li, Andy Peng Xiang, Qifa Liu

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  14. 14
    Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

    Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth за авторством Ningning Liu, Xiaofen Li, Hongbiao Huang, Chong Zhao, Siyan Liao, Changshan Yang, Shouting Liu, Wenbin Song, Xiaoyu Lu, Xiaoying Lan, Xin Chen, Songgang Yi, Li Xu, Lili Jiang, Canguo Zhao, Xiaoxian Dong, Ping Zhou, Shujue Li, Shunqing Wang, Xianping Shi, Q. Ping Dou, Xuejun Wang, Jinbao Liu

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  15. 15
    Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

    Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial за авторством Haiyan Zhang, Zhiping Fan, Fen Huang, Lijie Han, Yajing Xu, Na Xu, Lan Deng, Shunqing Wang, Dongjun Lin, Xiaodan Luo, Qing Zhang, Xiaodan Liu, Xudong Li, Xinquan Liang, Shuangfeng Xie, Hong Qu, Sijian Yu, Hongsheng Zhou, Pengcheng Shi, Li Xuan, Ren Lin, Hui Liu, Hua Jin, Jing Sun, Qifa Liu

    Опубліковано 2022
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  16. 16
    Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study

    Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study за авторством Wei Xu, Keshu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Yu Hu, Wei Zhang, Kaiyang Ding, Jianfeng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jianda Hu, Chunyan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xin‐Ran Tang, Bin Zhang, Jianyong Li

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  17. 17
    Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study

    Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study за авторством Ying‐Jun Chang, Depei Wu, Yongrong Lai, Qifa Liu, Yu‐Qian Sun, Jiong Hu, Yu Hu, Jianfeng Zhou, Juan Li, Shunqing Wang, Wei Li, Xin Du, Dongjun Lin, Hanyun Ren, Chen Fang-pin, Yuhua Li, Xi Zhang, He Huang, Yongping Song, Ming Jiang, Jianda Hu, Yingmin Liang, Jingbo Wang, Yang Xiao, Xiao‐Jun Huang

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: